Source:http://linkedlifedata.com/resource/pubmed/id/14656654
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2003-12-5
|
pubmed:abstractText |
In this study we investigated the effect of NF-kB signaling blockade on polymethylmethacrylate (PMMA) particle-induced osteoclastogenesis in vitro. We first established effective blockade of NF-kB activity as tested by electrophoretic mobility shift assays (EMSA). Particle-induced NF-kB activation in murine osteoclast precursor cells (CSF-1-dependent bone marrow macrophages) was markedly reduced by co-treatment of the cells with the NF-kB inhibitors N-tosyl-L-phenylalanine chloromethyl ketone (TPCK) and Calpain Inhibitor I (CPI). This inhibition of NF-kB activity was associated with blockade of p50 NF-kB subunit nuclear translocation. We then established a direct NF-kB inhibition approach by utilizing a TAT-bound, mutant IkB (TAT:IkB(46-317)), and demonstrated an inhibitory effect evidenced by decreased NF-kB DNA binding activity. Having established that these strategies (TPCK, CPI, TAT: IkB(46-317)) effectively block NF-kB activation, we next investigated the effect of these agents on particle-stimulated osteoclast formation. PMMA particle stimulation of mature osteoclast formation from RANKL-primed osteoclast precursor cells was blocked by all three inhibitors. To further test the efficacy of NF-kB blockade, experiments were performed with the TAT:IkB(46-317) mutant peptide in whole bone marrow cultures that contain supporting stromal cells. Again, this inhibitor efficiently blocked particle-induced osteoclastogenesis. Thus, we have shown that pharmaceutical and molecular blockade of NF-kB activation inhibits PMMA particle-directed osteoclastogenesis in vitro.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Bone Cements,
http://linkedlifedata.com/resource/pubmed/chemical/Cysteine Proteinase Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Glycoproteins,
http://linkedlifedata.com/resource/pubmed/chemical/NF-kappa B,
http://linkedlifedata.com/resource/pubmed/chemical/Polymethyl Methacrylate,
http://linkedlifedata.com/resource/pubmed/chemical/calpain inhibitors
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0736-0266
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
22
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
13-20
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:14656654-Animals,
pubmed-meshheading:14656654-Bone Cements,
pubmed-meshheading:14656654-Cysteine Proteinase Inhibitors,
pubmed-meshheading:14656654-Glycoproteins,
pubmed-meshheading:14656654-Mice,
pubmed-meshheading:14656654-Mice, Inbred C57BL,
pubmed-meshheading:14656654-NF-kappa B,
pubmed-meshheading:14656654-Osteoclasts,
pubmed-meshheading:14656654-Polymethyl Methacrylate,
pubmed-meshheading:14656654-Signal Transduction,
pubmed-meshheading:14656654-Stem Cells
|
pubmed:year |
2004
|
pubmed:articleTitle |
NF-kB signaling blockade abolishes implant particle-induced osteoclastogenesis.
|
pubmed:affiliation |
Department of Orthopaedic Surgery, Barnes-Jewish Hospital at Washington University School of Medicine, One Barnes-Jewish Hospital Plaza, Suite 11300, West Pavillion, St. Louis, MO 63110, USA. jclohisy@msnotes.wustl.edu
|
pubmed:publicationType |
Journal Article,
In Vitro,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|